CWM
TXG icon

CIBC World Markets’s 10x Genomics TXG Stock Holding History

CIBC World Markets’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$151K Buy
+13,012
New +$119K ﹤0.01% 1337

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC World Markets's TXG Position: Q2 2025 in Review

CIBC World Markets opened a new position in 10x Genomics (TXG) in Q2 2025: 13,012 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #1337 among its holdings.

297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • CIBC World Markets held 13,012 shares of 10x Genomics worth $151K as of Q2 2025.
  • 10x Genomics was a new CIBC World Markets position in Q2 2025.
  • 10x Genomics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1337 holding.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.